Intermediate CD14++CD16+ monocytes selectively express C–C chemokine receptor type 5 (CCR5) [4], secret more inflammatory cytokines such as tumor necrosis factor-α and interleukin-1β [3], and have been shown to drive atherosclerosis [5]. This evidence concerns the gene CD14 and atherosclerosis.